Center for Drug Evaluation and Research | 1260.1 |
Office of the Center Director | 1261.1 |
Office of Regulatory Policy | 1260.2 |
Division of Regulatory Policy I | 1260.21 |
Division of Regulatory Policy II | 1260.22 |
Division of Information Disclosure Policy | 1260.23 |
Division of Regulatory Policy III | 1260.24 |
Division of Regulatory Policy IV | 1260.25 |
Office of Management | 1261.10 |
Division of Budget Execution and Resource Management | 1261.11 |
Division of Management Services | 1261.17 |
Division of User Fee Management and Budget Formulation | 1261.18 |
Office of Communications | 1261.20 |
Division of Digital and Online Communications | 1261.22 |
Division of Health Communication | 1261.25 |
Division of Drug Information | 1261.26 |
Office of Surveillance and Epidemiology | 1261.5 |
Office of Medication Error Prevention and Risk Management | 1261.57 |
Division of Medication Error Prevention and Analysis I | 1261.571 |
Division of Risk Management | 1261.572 |
Division of Medication Error Prevention and Analysis II | 1261.573 |
Division of Mitigation Assessment and Medication Error Surveillance | 1261.574 |
Office of Pharmacovigilance and Epidemiology | 1261.58 |
Division of Epidemiology I | 1261.581 |
Division of Epidemiology II | 1261.582 |
Division of Pharmacovigilance I | 1261.583 |
Division of Pharmacovigilance II | 1261.584 |
Office of Compliance | 1262.1 |
Office of Unapproved Drugs and Labeling Compliance | 1262.3 |
Division of Compounded Drugs | 1262.31 |
Division of Unapproved New Drugs | 1262.32 |
Office of Manufacturing Quality | 1262.4 |
Division of Drug Quality I | 1262.45 |
Division of Drug Quality II | 1262.46 |
Division of Drug Quality III | 1262.47 |
Office of Scientific Investigations | 1262.5 |
Division of Good Clinical Practice Compliance | 1262.52 |
Division of Safety Compliance | 1262.53 |
Division of Enforcement and Postmarket Safety | 1262.54 |
Division of Clinical Compliance Evaluation | 1262.55 |
Office of Drug Security, Integrity and Response | 1262.6 |
Division of Global Drug Distribution and Policy | 1262.61 |
Division of Supply Chain Integrity | 1262.62 |
Office of Program and Regulatory Operations | 1262.7 |
Office of Compounding Quality and Compliance | 1262.8 |
Division of Compounding I | 1262.81 |
Division of Compounding II | 1262.82 |
Division of Compounding Policy and Outreach | 1262.83 |
Office of New Drugs | 1263.1 |
Office of Administrative Operations | 1263.11a |
Office of Nonprescription Drugs | 1263.12a |
Division of Nonprescription Drugs I | 1263.121 |
Division of Nonprescription Drugs II | 1263.122 |
Office of Specialty Medicine | 1263.13a |
Division of Ophthalmology | 1263.131 |
Division of Imaging & Radiation Medicine | 1263.132 |
Office of New Drug Policy | 1263.14a |
Division of Clinical Policy | 1263.141 |
Division of Regulatory Policy | 1263.142 |
Office of Regulatory Operations | 1263.15a |
Division of Regulatory Operations for Infectious Disease | 1263.151 |
Division of Regulatory Operations for Oncologic Disease | 1263.152 |
Division of Regulatory Operations for Nonprescription Drugs | 1263.153 |
Division of Regulatory Operations for Neuroscience | 1263.154 |
Division of Regulatory Operations for Cardiology, Hematology, Endocrinology & Nephrology | 1263.155 |
Division of Regulatory Operations for Immunology & Inflammation | 1263.156 |
Division of Regulatory Operations for Rare Diseases, Pediatrics, Urology & Reproductive Medicine | 1263.157 |
Division of Regulatory Operations for Specialty Medicine | 1263.158 |
Office of Program Operations | 1263.16a |
Office of Drug Evaluation Science | 1263.17a |
Division of Clinical Outcome Assessment | 1263.171 |
Division of Biomedical Informatics, Research & Biomarker Development | 1263.172 |
Office of Neuroscience | 1263.20 |
Division of Neurology I | 1263.21a |
Division of Neurology II | 1263.24a |
Division of Psychiatry | 1263.25 |
Division of Anesthesiology, Addiction Medicine & Pain Medicine | 1263.26 |
Division of Pharmacology Toxicology for Neuroscience | 1263.27 |
Office of Cardiology, Hematology, Endocrinology & Nephrology | 1263.30 |
Division of Diabetes, Lipid Disorders & Obesity | 1263.31 |
Division of General Endocrinology | 1263.32 |
Division of Cardiology & Nephrology | 1263.35 |
Division of Non-Malignant Hematology | 1263.36 |
Division of Pharmacology Toxicology for Cardiology, Hematology, Endocrinology & Nephrology | 1263.37 |
Office of Immunology & Inflammation | 1263.40 |
Division of Gastroenterology | 1263.42 |
Division of Dermatology & Dentistry | 1263.45 |
Division of Rheumatology & Transplant Medicine | 1263.46 |
Division of Pulmonology, Allergy & Critical Care | 1263.47 |
Division of Hepatology & Nutrition | 1263.48 |
Division of Pharmacology Toxicology for Immunology & Inflammation | 1263.49 |
Office of Infectious Diseases | 1263.50 |
Division of Anti-Infectives | 1263.51 |
Division of Antivirals | 1263.52 |
Division of Pharmacology Toxicology for Infectious Diseases | 1263.53a |
Office of Rare Diseases, Pediatrics, Urology & Reproductive Medicine | 1263.60 |
Division of Pharmacology Toxicology for Rare Diseases, Pediatrics, Urology & Reproductive Medicine | 1263.61a |
Division of Rare Diseases & Medical Genetics | 1263.62a |
Division of Urology, Obstetrics, & Gynecology | 1263.63a |
Division of Pediatric & Maternal Health | 1263.67 |
Office of Oncologic Diseases | 1263.70 |
Division of Oncology I | 1263.74 |
Division of Hematologic Malignancies I | 1263.75 |
Division of Oncology II | 1263.76 |
Division of Hematology Oncology Toxicology | 1263.77 |
Division of Oncology III | 1263.79 |
Division of Hematologic Malignancies II | 1263.80 |
Office of Therapeutic Biologics and Biosimilars | 1263.90 |
Office of Medical Policy | 1266.1 |
Office of Prescription Drug Promotion | 1266.11 |
Division of Advertising and Promotion Review II | 1266.111 |
Division of Advertising and Promotion Review I | 1266.112 |
Office of Medical Policy Initiatives | 1266.12 |
Division of Medical Policy Development | 1266.121 |
Division of Medical Policy Programs | 1266.122 |
Division of Clinical Trial Quality | 1266.123 |
Office of Executive Programs | 1267.1 |
Division of Learning and Organizational Development | 1267.11 |
Division of Advisory Committee and Consultant Management | 1267.13 |
Office of Translational Sciences | 1268.1 |
Office of Biostatistics | 1268.3 |
Division of Biometrics I | 1268.31 |
Division of Biometrics II | 1268.32 |
Division of Biometrics III | 1268.33 |
Division of Biometrics IV | 1268.34 |
Division of Biometrics V | 1268.35 |
Division of Biometrics VI | 1268.36 |
Division of Biometrics VII | 1268.37 |
Division of Biometrics VIII | 1268.38 |
Division of Biometrics IX | 1268.39 |
Office of Clinical Pharmacology | 1268.4 |
Division of Neuropsychiatric Pharmacology | 1268.41 |
Division of Inflammation & Immune Pharmacology | 1268.42 |
Division of Cardiometabolic & Endocrine Pharmacology | 1268.43 |
Division of Infectious Disease Pharmacology | 1268.44 |
Division of Cancer Pharmacology I | 1268.45 |
Division of Pharmacometrics | 1268.46 |
Division of Applied Regulatory Science | 1268.47 |
Division of Cancer Pharmacology II | 1268.48 |
Division of Translational & Precision Medicine | 1268.49 |
Office of Computational Science | 1268.5 |
Division of Regulatory Review & Research | 1268.51 |
Division of Tools, Technology & Innovation | 1268.52 |
Office of Study Integrity and Surveillance | 1268.6a |
Division of New Drug Study Integrity | 1268.61 |
Division of Generic Drug Study Integrity | 1268.62 |
Office of Administrative Operations | 1268.7 |
Office of Strategic Programs | 1270.2 |
Office of Program and Strategic Analysis | 1270.21 |
Office of Business Informatics | 1270.22 |
Division of Drug Quality and Compliance Services Solution | 1270.222 |
Division of Data Management Services and Solutions | 1270.223 |
Division of Business Management Services and Solutions | 1270.224 |
Division of Regulatory Review and Drug Safety Services Solutions | 1270.225 |
Office of Pharmaceutical Quality | 1280.1a |
Office of Administrative Operations | 1280.11 |
Office of Biotechnology Products | 1280.20 |
Division of Biotechnology Review and Research I | 1280.21 |
Division of Biotechnology Review and Research II | 1280.22 |
Division of Biotechnology Review and Research III | 1280.23 |
Division of Biotechnology Review and Research IV | 1280.24 |
Office of New Drug Products | 1280.30 |
Division of Life Cycle API | 1280.31 |
Division of New Drug API | 1280.32 |
Division of New Drug Products I | 1280.33 |
Division of New Drug Products II | 1280.34 |
Division of Biopharmaceutics | 1280.35 |
Division of New Drug Products III | 1280.36 |
Office of Policy for Pharmaceutical Quality | 1280.40 |
Division of Regulations, Guidance and Standards | 1280.41 |
Division of Internal Policies and Programs | 1280.42 |
Office of Pharmaceutical Manufacturing Assessment | 1280.50 |
Division of Pharmaceutical Manufacturing I | 1280.51 |
Division of Pharmaceutical Manufacturing II | 1280.52 |
Division of Pharmaceutical Manufacturing III | 1280.53 |
Division of Pharmaceutical Manufacturing IV | 1280.54a |
Division of Microbiology Assessment I | 1280.55a |
Division of Microbiology Assessment II | 1280.56 |
Division of Biotechnology Manufacturing | 1280.57 |
Office of Quality Surveillance | 1280.60 |
Division of Quality Data Science | 1280.61 |
Division of Quality Intelligence I | 1280.62 |
Division of Quality Intelligence II | 1280.63 |
Office of Testing and Research | 1280.70 |
Division of Product Quality Research | 1280.71 |
Division of Pharmaceutical Analysis | 1280.72 |
Division of Complex Drug Analysis | 1280.73 |
Office of Program and Regulatory Operations | 1280.80 |
Division of Regulatory and Business Process Management I | 1280.81 |
Division of Regulatory and Business Process Management II | 1280.82 |
Division of Regulatory & Business Process Management III | 1280.83a |
Division of Operational Excellence, Learning & Professional Development | 1280.84 |
Office of Lifecycle Drug Products | 1280.90 |
Division of Immediate & Modified Release Products I | 1280.91 |
Division of Immediate Release Products II | 1280.92 |
Division of Immediate & Modified Release Products III | 1280.93 |
Division of Liquid-Based Products I | 1280.94 |
Division of Liquid-Based Products II | 1280.95a |
Division of Post-Marketing Activities I | 1280.96a |
Division of Post-Marketing Activities II | 1280.97 |
Office of Generic Drugs | 1290.1a |
Office of Research and Standards | 1291.1a |
Division of Therapeutic Performance | 1291.11 |
Division of Quantitative Methods and Modeling | 1291.12 |
Office of Bioequivalence | 1292.1a |
Division of Bioequivalence I | 1292.11 |
Division of Bioequivalence II | 1292.12 |
Division of Bioequivalence III | 1292.13 |
Division of Clinical Review | 1292.14 |
Office of Generic Drug Policy | 1293.1a |
Division of Legal and Regulatory Support | 1293.11 |
Division of Policy Development | 1293.12 |
Office of Regulatory Operations | 1294.1a |
Division of Labeling Review | 1294.11 |
Division of Filing Review | 1294.12 |
Division of Project Management | 1294.13 |
Division of Quality Management Systems | 1294.14 |